Non-specific cellular immunity in type I and type II diabetes

Experimental and Clinical Endocrinology
J FövenyiT Garam

Abstract

Antibody-dependent cellular cytotoxicity (ADCC) against human erythrocytes was investigated in 39 type I and 63 type II diabetic patients in comparison to 177 healthy blood donors. The cytotoxic capacity of lymphocytes from diabetics was significantly increased. The highest values were measured in insulin-treated type II diabetics (after secondary failure of a previous sulfonylurea therapy).--It is suggested that in certain cases of type II diabetes an increased unspecific K cell-and/or antibody-dependent cellular cytotoxicity plays a pathogenetic role in the development of the disease. The latter might possibly be directed against insulin receptors.

Citations

Sep 1, 1988·Diabetologia·A D MooradianJ E Morley
Jul 1, 1986·The American Journal of Medicine·C B NiewoehnerJ E Morley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.